Published in Proc Natl Acad Sci U S A on June 06, 2000
Distribution and characterization of regulatory elements in the human genome. Genome Res (2002) 3.34
Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol (2011) 3.15
Human telomerase and its regulation. Microbiol Mol Biol Rev (2002) 3.11
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood (2008) 2.87
Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Res (2012) 2.66
Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet (2011) 2.48
DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma (2009) 2.13
Maternal cocaine administration causes an epigenetic modification of protein kinase Cepsilon gene expression in fetal rat heart. Mol Pharmacol (2007) 1.59
Characterization of the genomic Xist locus in rodents reveals conservation of overall gene structure and tandem repeats but rapid evolution of unique sequence. Genome Res (2001) 1.54
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy. Mutat Res (2008) 1.45
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem (2008) 1.39
Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci (2008) 1.39
Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proc Natl Acad Sci U S A (2010) 1.37
Epigenetic modification of fetal baboon hepatic phosphoenolpyruvate carboxykinase following exposure to moderately reduced nutrient availability. J Physiol (2010) 1.35
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer (2009) 1.26
Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem (2013) 1.24
The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid Redox Signal (2011) 1.24
CpG methylation of DNA restricts prereplication complex assembly in Xenopus egg extracts. Mol Cell Biol (2003) 1.21
Foetal nicotine exposure causes PKCε gene repression by promoter methylation in rat hearts. Cardiovasc Res (2010) 1.14
Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J (2009) 1.14
Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci (2015) 1.09
Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation. FASEB J (2007) 1.09
Fetal exposure to cocaine causes programming of Prkce gene repression in the left ventricle of adult rat offspring. Biol Reprod (2008) 1.04
Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-α gene in ovine uterine arteries via heightened promoter methylation. Hypertension (2012) 1.03
Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. Nucleic Acids Res (2004) 1.02
Conservation and regulatory associations of a wide affinity range of mouse transcription factor binding sites. Genomics (2010) 1.02
CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding. Nucleic Acids Res (2007) 1.01
CG methylation. Epigenomics (2012) 0.99
CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene. Biochem J (2006) 0.97
DNA methylation, its mediators and genome integrity. Int J Biol Sci (2015) 0.96
Analysis of intron sequence features associated with transcriptional regulation in human genes. PLoS One (2012) 0.93
Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance. Neoplasia (2009) 0.92
Choline nutrition programs brain development via DNA and histone methylation. Cent Nerv Syst Agents Med Chem (2012) 0.89
Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genomics (2014) 0.87
Promoter methylation represses AT2R gene and increases brain hypoxic-ischemic injury in neonatal rats. Neurobiol Dis (2013) 0.86
CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a. Biochem J (2011) 0.86
A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. Int J Biol Markers (2010) 0.86
Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. Biochim Biophys Acta (2007) 0.86
Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PLoS One (2012) 0.85
Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia. Oncogene (2013) 0.81
Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A. PLoS One (2010) 0.81
Tissue-specific silencing of a transgene in rice. Proc Natl Acad Sci U S A (2002) 0.81
Epigenetic upregulation of large-conductance Ca2+-activated K+ channel expression in uterine vascular adaptation to pregnancy. Hypertension (2014) 0.80
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells. Nucleic Acids Res (2015) 0.80
Integrative analysis of methylome and transcriptome reveals the importance of unmethylated CpGs in non-CpG island gene activation. Biomed Res Int (2013) 0.79
Analysis method of epigenetic DNA methylation to dynamically investigate the functional activity of transcription factors in gene expression. BMC Genomics (2012) 0.79
Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.78
Hypermethylation of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. World J Gastrointest Oncol (2009) 0.78
Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring. PLoS One (2014) 0.78
Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells. BMC Cancer (2014) 0.78
High-resolution genome-wide DNA methylation maps of mouse primary female dermal fibroblasts and keratinocytes. Epigenetics Chromatin (2014) 0.77
Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications. Ther Adv Musculoskelet Dis (2015) 0.76
Don't worry; be informed about the epigenetics of anxiety. Pharmacol Biochem Behav (2016) 0.75
DNMT3B modulates the expression of cancer-related genes and downregulates the expression of the gene VAV3 via methylation. Am J Cancer Res (2017) 0.75
Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression. J Cell Biol (2015) 0.75
Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer. Oncotarget (2016) 0.75
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait. Epigenetics (2016) 0.75
Single-CpG resolution mapping of 5-hydroxymethylcytosine by chemical labeling and exonuclease digestion identifies evolutionarily unconserved CpGs as TET targets. Genome Biol (2016) 0.75
Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov (2016) 0.75
Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression. Curr Genomics (2017) 0.75
DNA methylation in oligodendroglial cells during developmental myelination and in disease. Neurogenesis (Austin) (2017) 0.75
High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy. Am J Pathol (2017) 0.75
MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter. Nucleic Acids Res (2017) 0.75
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Cancer cell cycles. Science (1996) 21.29
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
The regulation of E2F by pRB-family proteins. Genes Dev (1998) 12.77
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet (1999) 9.53
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med (1995) 9.10
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05
Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res (1989) 5.02
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci U S A (1987) 4.68
Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ (1998) 4.38
Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev (1992) 4.02
CpG islands and genes. Curr Opin Genet Dev (1995) 3.83
Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev (1993) 3.64
DNA methylation errors and cancer. Cancer Res (1996) 3.57
Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell (1998) 3.05
DNA methylation and cancer. Hum Mol Genet (1994) 2.84
The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol (1998) 2.53
DNA methylation in early development. Hum Mol Genet (1995) 2.45
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet (1991) 2.45
Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell (1998) 2.02
CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene (1993) 1.95
The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol (1996) 1.87
Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol (1997) 1.75
Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene (1998) 1.74
CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene (1998) 1.58
Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol (1998) 1.48
The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res (1996) 1.47
Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. Proc Natl Acad Sci U S A (1998) 1.16
Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells. Eur J Immunol (1995) 1.14
Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation. Blood (1991) 1.05
Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol (1999) 0.98
Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Nucleic Acids Res (1999) 0.96
Repression of the mouse M-lysozyme gene involves both hindrance of enhancer factor binding to the methylated enhancer and histone deacetylation. Nucleic Acids Res (1998) 0.91
Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol Cell Biol (1996) 0.89
Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells. Leukemia (1994) 0.79
Genetic alterations in human tumors. Curr Top Microbiol Immunol (1997) 0.78
Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol (1994) 2.95
Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 2.31
The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J (1996) 2.27
Effect of chronic home care on admission to institutions providing long-term care. Can Med Assoc J (1977) 1.46
Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. J Virol (1995) 1.24
The human thymidine kinase gene promoter. Deletion analysis and specific protein binding. J Biol Chem (1989) 1.18
Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology (2001) 1.15
Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol (2001) 1.10
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. Virology (1995) 1.04
Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci U S A (1992) 1.03
The impact of managed care on mental health services for children and their families. Future Child (1998) 0.92
Transfection-mediated cell-cycle signaling: considerations for transient transfection-based cell-cycle studies. Anal Biochem (1999) 0.85
Outcomes associated with clinical profiles of children in psychiatric crisis enrolled in intensive, in-home interventions. Ment Health Serv Res (2001) 0.79
Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol (1995) 0.77
Transfection-mediated cell synchronization: acceleration of G1-S phase transition by gamma irradiation. Biotechniques (2001) 0.77
Chronic home care in ontario: five year follow up. Can Fam Physician (1982) 0.75
Developing new certificate-of-need regulations for inpatient care of children in New York State. Hosp Community Psychiatry (1991) 0.75
Impact of managed care in the public sector: children and adolescents with behavioral health problems and their families. Behav Healthc Tomorrow (1998) 0.75
Assessing the outcomes of parent-and provider-designed systems of care for children with emotional and behavioral disorders. Psychiatr Q (1994) 0.75